StockData
NovaBridge Biosciences logo

NovaBridge Biosciences (NBP) stock

NBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 7, 2026Score 0/30
$0.82+0.03 (+3.89%)

Close on Nov 17, 2026Market cap $94.88MP/E –Yield –

Earnings

NovaBridge Biosciences's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of NovaBridge Biosciences's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2023ended Dec 31, 2023Mar 15, 2024before the open–––Release
Q2 FY2022ended Jun 30, 2022Aug 30, 2022before the open–––Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

NovaBridge Biosciences has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When NovaBridge Biosciences puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases NovaBridge Biosciences filed with the SEC as exhibits to Form 8-K or 6-K

  1. 6-K
  2. 6-K
  3. 6-K
  4. 6-K
  5. 6-K
  6. 6-K
  7. 6-K
  8. 6-K
  9. 6-K
  10. 6-K
  11. 6-K
  12. 6-K
  13. 6-K
  14. 6-K
  15. 6-K

See a number that looks wrong?